Retatrutide: One Thorough Look
The novel class of GLP-1 receptor agonist and GIP dual medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, represent promising improvements in metabolic management . Although
The novel class of GLP-1 receptor agonist and GIP dual medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, represent promising improvements in metabolic management . Although